Presentation is loading. Please wait.

Presentation is loading. Please wait.

Eye Care for Health Care Providers

Similar presentations


Presentation on theme: "Eye Care for Health Care Providers"— Presentation transcript:

1 Eye Care for Health Care Providers
Len Oshinskie, O.D. Chief, Optometry Section Newington VA Medical Center

2 Topics Laser-assisted Cataract surgery
Age-related macular degeneration Diabetic Macular Edema Glaucoma and Medications Red eye Dry eye Practical advice

3 Common Causes of Blindness and Visual Impairment
Age-related macular degeneration Diabetic retinopathy Glaucoma Cataract

4 Femtosecond laser Approved by FDA for several steps in cataract surgery in Uses laser energy at 1053 nm that is precise to 3 microns( lens capsule is 2-28 microns thick) Ultra short pulse does not damage surrounding tissue (10-15 of a sec)

5

6 Femtosecond laser assisted cataract surgery

7 Advantages to laser assisted cataract surgery
Incisions more reproducible than bladed incisions Less risk for capsular rupture More precise opening so IOL can be more accurately placed Less energy from phaco probe for at risk pts, less inflammation Perhaps less risk of infection

8 Disadvantages of laser assisted cataract surgery
Takes longer Requires expensive equipment Capsulorhexis not always complete Not paid for by Medicare Pts have higher expectations

9 Age-related macular degeneration
Leading cause of blindness over age 65 Drusen and pigment atrophy and clumping exudative changes(heme, lipid, small central retinal detachments) sudden distortion of vision, new unilateral blur, scotoma, difficulty reading

10 Macular Degeneration Types
Atrophic (dry) AMD % Neovascular(wet) AMD 10-20%

11

12 Drusen

13 AREDS 1 500 mg vit C 400 IU vit E 15 mg betacarotene 80 mg zinc
2 mg copper Over 5 yr followup reduced risk of progression to advanced AMD by 25 % if pt had certain macula findings(larger drusen)

14 AREDS 2 results May 2013 JAMA 2013: 309(19):2005-2015
Placebo controlled clinical trial(AREDS 1 was placebo) Multiple arms: lutein 10 mg/zeathanthin 2 mg, DHA(350 mg) and EPA(650 mg), both, AREDS 1 AREDS 1 formula with lutein/zeaxanthin(removing betacarotene) slightly reduced risk of developing advanced AMD Adding DHA and EPA did not reduce risk

15

16 Risks with AREDS 2 Large dose of vit E(prostate and heart failure)
Coumadin users

17 Genetics and AMD One study to suggest genetic testing maybe important before prescribing AREDS supplement

18 Exudative (Wet) AMD

19 Early exudative AMD

20

21

22 OCT ocular coherence tomography

23

24 Br J Ophthal 1997; 81: A significantly increased expression of VEGF (p= ) and TGF-β (p=0.019) was found in the retinal pigment epithelium (RPE) of maculae with AMD compared with control maculae.

25

26 Anti-VEGF medications
Macugen(Pegaptanib) 2004 Avastin(bevacizumab) 2005 but not FDA approved Lucentis(ranibizumab) 2006 Eylea(aflibercept) 2011

27 Intravitreal injection

28 Studies on Treatment of Wet AMD (ETDRS visual acuity chart)

29

30

31 Visual Acuity with Eylea

32 Ocular side effects Cataract Inflammation Retinal detachment
endophthalmitis

33 Jetrea(ocriplamin) Intravitreal injection
Approved for treatment of vitreo-retinal adhesions Side effects-transient vision decrease and inflammation

34 Aspirin use in pts with wet AMD
Conflicting reports Recent studies suggest an increased risk, but not randomized If risks for CV complications, suggest continuing ASA

35 Trends in Treating Diabetic Retinopathy

36 Mechanism of Diabetic Macular Edema
Hyperglycemiathickened endothelial cellsIschemia  increased VEGF, loss of pericytes Macular edema : increased permeability increased hydrostatic pressure dilating blood vessels, pericytes disrupted Inflammatory component

37 Treatment of Diabetic Macular Edema
Anti-VEGF treatment Corticosteroids Laser

38 Anti-VEGF treatment of DME
Lucentis more effective than sham or laser in decreasing thickness and improving vision Lucentis as adjunct to laser more effective than laser alone in decreasing thickness and improving vision Eylea showed improved vision compared to laser Lucentis approved by FDA for Tx of DME

39 What to tell your patients about intravitreal injections
Does not hurt as much as you think Very safe (2.1% have ocular complications) Multiple injections needed Very effective in preventing vision loss It usually take several weeks for vision to improve/stabilize Post op: expect mild soreness, irritation, floaters, subconj heme Report any sudden vision changes or pain stat There may be small risk for CVA

40 Marijuana and glaucoma
AAO June 2014 recommendations: Only lowers IOP 3-4 hours Not as effective as available medications Potential for abuse Potential for lung damage Lowers BP (less perfusion) Topical THC drops tried but not effective(not water soluble enough) effects of Marinol on glaucoma are not impressive No standardization of dose with various forms of marijuana plants Not legal in federal system

41 Plaquenil Monitoring Visual field OCT and FAF Focal ERG

42 Topiramate Angle closure glaucoma Visual field defects

43 Tear film composition Lipid, aqueous, mucin

44

45 Tear film components Lipid-Meibomian glands aqueous-lacrimal gland
Mucin-goblet cells Ideal tear film has uniform thickness maintains corneal coverage between blinks limited debris

46

47 Dry eye Multifactorial disease of tears and ocular surface
Discomfort, vision changes and tear film instability Decreased tear production, increased osmolarity and inflammation of ocular surface

48 Dry Eye Cascade Clin Ophthalmol. 2009; 3: 405–412.

49 Guidelines from the 2007 International Dry Eye Workshop BY MICHAEL A
Guidelines from the 2007 International Dry Eye Workshop BY MICHAEL A. LEMP, M. D. AND GARY N. FOULKS, M. D. .

50 Dry Eye Disease Stevenson et al in Arch Ophthalmology 2012;130:90-100

51 Dry Eye Symptoms Dryness Irritation/burning(“hurt”)
Foreign body sensation(“sand in my eyes”) Watering Intermittent blurred vision Itching

52 Differential Diagnosis Pt with Symptoms of Dry Eye
Blepharitis Rosacea Exposure keratitis (TAO, CN 7 palsy,ectropion )

53

54 Risk factors for Dry Eye Stevenson et al
Risk factors for Dry Eye Stevenson et al. Arch Ophthalmology 2012;130:90-100 Increased age Female >males Hormonal inbalance Autoimmune disease Vitamin deficiency Medications Environmental stress Contact lens use Ophthalmic surgery(LASIK)

55 Contributors to Dry Eye
Air flow(AC, fans etc) Humidity Smoke Alcohol Antihistamines Diuretics Blink rate(reading and computer)

56 Evaluation of the Dry Eye Patient
History Tear Breakup time-quality Schirmer-quantity Corneal staining(fluorescein or lissamine green) Tear wedge-quantity Osmolarity

57

58 Break up Time

59 Corneal staining

60 Tear Wedge

61 Lid Position Proptosis Lagophthalmus Ectropion Parkinson’s
CN VII palsy Partial blinker Sleep apnea

62 Treatment Artificial tears-preserved and non-preserved
Restasis(topical cyclosporin A) Topical corticosteroids Omega 3/Fish Oil Qhs ointment Tetracyclines Punctal plugs tarsorrhaphy

63 Using Artificial tears
Avoid OTC “gets the red out” drops Use drops that say lubricant or artificial tears Must use 4 times a day Don’t touch tip of bottle to eye or lids Systane Balance Refresh Optive Advanced FreshKote(by Rx only) Give ointment at night ?

64 Punctal plugs

65

66 My patient has glaucoma, is it safe to prescribe them_____?
antihistamines tricyclic antidepressants Parkinson's disease anti-cholinergics such as atropine anti-spasmolytics anti-psychotic medications

67 Glaucoma Classification
Primary, chronic or idiopathic type(open angle) secondary forms: pseudoexfoliation, pigmentary, uveitic, steroid induced, traumatic, post-op, others) low-tension or normal-tension type developmental type angle-closure type

68 Narrow angle and dilated pupil

69 Meds to avoid if pt has narrow angles
Antihistamines and decongestants: Pseudoephedrine, diphenhydramine , hydroxyzine, and clemastine fumarate Asthma medicines: Albuterol, metaproterenol sulfate, isoetharine, and theophylline Motion sickness medicines: Scopolamine and dimenhydrinate Tricyclic antidepressants, such as amitriptyline, nortriptyline , doxepin, clomipramine amoxapine, chlordiazepoxide and amitriptyline ), trimipramine and imipramine.

70 Risk factors for acute angle-closure glaucoma
Age 55-70 Hyperopia females Asians

71 Signs/Symptoms of Acute Angle Closure Glaucoma
Pain hazy/blurred vision haloes around lights frontal HA nausea/vomiting Fixed pupil Steamy cornea Red eye

72 Glaucoma Medications Prostaglandin analogs(Xalatan, Lumigan, Travatan Z, Zioptan, latanoprost) beta-blockers( Ocupress, Betagan, Betoptic S, Betimol, Istalol, timolol) alpha agonist(Alphagan P, brimonidine) CAI(Trusopt, Azopt, dorzolamide) Combo meds(Cosopt, Combigan, Simbrinza) miotics(pilocarpine) Oral carbonic anhydrase inhibitors(Diamox)

73 Differential Diagnosis of the Red Eye
Infectious(bacterial, viral, fungal) Inflammatory(uveitis, episcleritis,scleritis) Increased IOP Allergic Mechanical(lid, FB, contact lens) Dry eye Toxic

74 Differential Diagnosis of the Red Eye
Systemic disorders/dermatologic disease thryroid disease Chlamydia rosacea atopic dermatitis subconjunctival hemorrhage

75 When to refer the red eye
History important for deciding when to refer Refer if associated with : Blur Pain Hx of narrow angles Pupil unresponsive to light Hx of Herpes keratitis or zoster, light sensitivity Contact lens wearer Chemical injury involving alkaline

76 Clinical exam Stain the cornea with fluorescein
examine lids(entropion, bleparitis) pupil(ACG, uveitis) cul-de-sacs for FB

77 Older Ophthalmic antibiotics
Erythromycin Sulfacetamide gentamicin neomycin/polymyxin B/gramicidin/dexamethasone(Maxitrol)

78 Current trends Fluoroquinolones(Vigamox/Moxema, Zymaxid, Quixin/Iquix, Besivance) Tobradex(beware steroids) Polytrim(trimethoprim/polymyxin B) Polysporin ointment

79 When to refer the red eye
Vision changes Pain Redness getting worse History of narrow angles Light sensitivity Fixed pupil or steamy cornea Previous bouts of uveitis or Herpes simplex keratitis

80 Urgent Eye/Visual Symptoms
eye pain(keratitis, uveitis, ACG) photophobia(keratitis, uveitis) numerous floaters(retinitis, RD, VH) sudden onset distortion or blur(AMD) sudden unilateral vision loss(CRAO/CRVO, RD, AION) red eye with blur(ACG, keratitis, posterior uveitis) Fixed pupil with pain or diplopia

81 Topical Steroids Increases IOP in 10-15%
allow proliferation of destructive organisms(HSK, Pseudomonas) cataracts duty to warn limit refills Try Lotemax


Download ppt "Eye Care for Health Care Providers"

Similar presentations


Ads by Google